Study which tests 2 medications (SB27, Keytruda) to compare how effective, safe and well tolerated in a large number of metastatic non-squamous non-small cell lung cancer patients
Phase 1
Recruiting
- Conditions
- on-small Cell Lung CancerTherapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-507448-36-00
- Lead Sponsor
- Samsung Bioepis Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 616
Inclusion Criteria
Male or female = 18 years of age, Have been diagnosed with stage IV non-squamous NSCLC, Have not received any prior systemic anti-cancer therapy for metastatic NSCLC, Agree to use adequate methods of contraception
Exclusion Criteria
Unable to take folic acid and vitamin B12 supplementation, Unable to receive chemotherapy during the study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method